Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Sun Pharma Adv
Sun Pharma Adv
BSE: 532872NSE: SPARCISIN: INE232I01014

26th-May-2020 20:23Source: BSE

Sun Pharma Advanced Research Company - Board Meeting Intimation for Notice Of Board Meeting For Consideration Of Audited Results Of The Company For The Fourth Quarter And Financial Year Ended 31St March 2020.

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/06/2020 ,inter alia, to consider and approve Pursuant to regulation 29 (1) of the SEBI (Listing obligation & Disclosure Requirements) Regulation, 2015, we hereby inform you that a meeting of the Board of Directors of Sun Pharma Advanced Research Company Limited will be held on Tuesday, 2nd June 2020, inter alia, to consider and approve, the audited financial results of the Company for the fourth quarter and financial year ended 31st March 2020.

In view of the above and pursuant to the Company''s Code of Conduct for Prevention of Insider Trading, the trading window for trading by designated persons, shall remain closed upto 4th June 2020 i.e. 48 hours after the declaration of financial results of the Company on 2nd June 2020.

More Announcements on:

1 2 3 4 5 Next >>
Sections